tonefotografia /
7 October 2016Americas

Shire wins Lialda PTAB case against Bass

Hedge fund manager Kyle Bass has lost a patent case against Shire over the drug Lialda (mesalamine).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at